Summit Therapeutics Jumps on $2 Billion AstraZeneca Investment
Summit Therapeutics Inc. shares rose after it said AstraZeneca Plc would make a $2 billion strategic equity investment in the cancer drugmaker to jointly develop drugs.
Read the full story at Bloomberg Markets ↗
ImpactNotable 40/100
Why it mattersRule-based estimate: event keywords (+6); trust 9/10.
RegionsGlobal
Published3 h ago (Mon, 28 Sep 2026 21:42:10 GMT)
RetrievedMon, 28 Sep 2026 22:00:41 GMT via rss
ClassifiedMon, 28 Sep 2026 22:00:58 GMT by heuristic
AuthorJohn Tozzi